Eli Lilly opposes push to pass Trump's drug pricing deals into law, CEO says
Eli Lilly opposes the White House's push to codify "most favored nation" drug pricing into law, CEO Dave Ricks said in an interview with CNBC.
Last updated: 2026-04-01 20:34:18 ET
Eli Lilly opposes the White House's push to codify "most favored nation" drug pricing into law, CEO Dave Ricks said in an interview with CNBC.
Trump says he expects the U.S. war with Iran to end within several weeks despite unrelenting attacks from both sides and Iran's iron grip on the Strai...
Eli Lilly opposes the White House's push to codify "most favored nation" drug pricing into law, CEO Dave Ricks said in an interview with CNBC.
Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug.
Kentucky Sen. Rand Paul addresses President Trump's decision to launch strikes against Iran, the new Department of Homeland Security secretary and the...
As chairman of the Homeland Security Committee, Sen. Rand Paul is at the center of some of the country's most critical debates. He speaks with Robert ...
Retired FBI profiler Candice DeLong says Karla Faye Tucker's troubled childhood and drug use doomed her long before the 1983 pickaxe murders that...
U.S. pharmaceutical giant Eli Lilly will give Hong Kong-listed Insilico $115 million upfront to bring some of its AI-discovered drugs to the global ...
Kim Jong Un oversaw a new solid-fuel rocket engine test, state media reports, as North Korea pushes to upgrade its long-range strategic strike capabil...
War continues to escalate with Yemen’s Iran-backed Houthis confirming a second wave of attacks on Israel since they joined the war on SaturdayRead t...
Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.
LOG IN / SUBSCRIBE